AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.
The Company is investigating novel molecules within the CYB005 program at non-hallucinogenic doses for a range of Central Nervous System (“CNS”) disorders. In addition, the Company is continuing to ...
Laser treatment for nail psoriasis: Six treatments, which were given once a month with a pulsed dye laser, lead to noticeably less nail discoloration, crumbling, and pitting. Phototherapy is a ...
Given that acne can lead to such experiences and feelings, it’s not surprising that researchers have found that people with acne often develop depression or anxiety. Studies show that the longer acne ...